Novartis New Organizational Model

SG&A savings fully embedded by 2024, mainly from efficiencies in operations, M&S duplication and G&A streamlining Estimated annual savings Illustrative 17 ≥USD 1bn Integrated Operations unit synergies Simplification of M&S structure (non-customer-facing) Streamlining G&A functions 2022 2023 2024 Minimal 2022 impact, offsetting energy costs and inflation pressure in supply chain NOVARTIS NEW ORGANIZATIONAL MODEL | APRIL 04, 2022 | NOVARTIS INVESTOR PRESENTATION One-time restructuring cost estimated at 1 to 1.5x annual structural savings NOVARTIS | Reimagining Medicine

View entire presentation